<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Oncology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/001A9792-C636-4B75-A8D4-A3C1B55359DC"><gtr:id>001A9792-C636-4B75-A8D4-A3C1B55359DC</gtr:id><gtr:firstName>Ashok</gtr:firstName><gtr:surname>Venkitaraman</gtr:surname><gtr:orcidId>0000-0002-6876-2672</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1001521"><gtr:id>B7C9F7E4-8420-4538-BFC2-8050224ECD99</gtr:id><gtr:title>Chromosomal Instability in Cancer Pathogenesis and Treatment (MRC Programme 1)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1001521</gtr:grantReference><gtr:abstractText>Normal cells tightly control the duplication and integrity of their genetic information encoded in chromosomes, and its segregation into daughter cells during cell division (mitosis). They use complex pathways for DNA repair and mitosis to achieve this. There is mounting evidence that these pathways are disrupted early in the evolution of cancer, leading to instability of chromosome structure and number that promotes the progression of the disease. We are studying human genetic diseases where chromosome instability is associated with cancer to understand the pathways that control DNA repair and mitosis, and how they are altered in cancer cells. Because the majority of drugs currently used to treat cancer affect these pathways, we are studying how alterations in them can affect the response of cancer cells to treatment.</gtr:abstractText><gtr:technicalSummary>Instability in the structure and number of chromosomes is a hallmark of virtually all human epithelial cancers, and is triggered early during their development. What provokes chromosomal instability, and how it fosters cancer pathogenesis, are major unresolved questions central to understanding carcinogenesis. The near-universal occurrence of chromosomal instability in common epithelial malignancies offers important opportunities for devising new approaches to cancer therapy, which remain to be explored.

This programme aims: To understand the mechanisms that engender chromosomal instability and define their contribution to epithelial carcinogenesis. In so doing, to develop new approaches for cancer therapy that can be applied in the clinic, exploiting the novel interdisciplinary platforms being developed in the Cambridge Molecular Therapeutics Programme (CMTP).

Each future project builds on new discoveries and experimental approaches from the last quinquennium, and represents a progression from mechanistic studies towards their translation to cancer pathogenesis and treatment.
We will investigate how cancer-associated mutations in BRCA2 affect the new tumour suppressive functions we have recently discovered, using a range of new fluorescence imaging methods we have established to probe BRCA2 function at single-molecule resolution in vitro and in vivo.

We will define the molecular evolution of BRCA2-deficient familial pancreatic cancer using powerful genomic and proteomic approaches in a new murine model, and use it as a test-bed for new treatments, including a first-in-class drug exploiting a new approach (Targeted Synergy) to selectively kill hypoxic tumour cells.
We will use the functional genomics platforms now established in our lab to identify new molecular components of the pathways discovered in the last quinquennium that determine the response of cancer cells to agents that inhibit DNA repair or mitosis. Clinical collaborations will test the value of new pathway mediators as prognostic or predictive biomarkers in patients with epithelial cancers.</gtr:technicalSummary><gtr:fund><gtr:end>2016-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1964410</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Chris Abell, David Spring</gtr:description><gtr:id>FA344AFF-33D8-4776-9B3E-DC57E753CE2E</gtr:id><gtr:impact>Outputs: Grant income &amp;gt;&amp;pound;7M, several joint coauthored publications.

Multidisciplinary: Our MRC-funded team- protein biochemistry, structural biology, molecular cell biology, biophysics, assay development, computational modeling and structural chemistry, molecular imaging. Partners- organic synthetic chemistry</gtr:impact><gtr:outcomeId>NiLEDsEVQX8-1</gtr:outcomeId><gtr:partnerContribution>Our partners bring skills in organic synthetic chemistry.</gtr:partnerContribution><gtr:piContribution>This forms part of a multi-disciplinary collaboration to pioneer new approaches for the discovery and development of chemical tools that modulate new structural classes of molecular targets for chemical biology and therapeutics development. The MRC-funded research team in my laboratory contributes to work in protein biochemistry, structural biology, molecular cell biology, biophysics, assay development, computational modeling and structural chemistry, and molecular imaging.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Feature on Cambridge University news site</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>31B6BB89-0F7B-4F42-968A-43296972978F</gtr:id><gtr:impact>Appeared in Cambridge University news feature on appointment as Jubilee Professor by Indian Academy of Sciences. http://news.admin.cam.ac.uk/news/2012/06/27/cambridge-scientist-appointed-inaugural-jubilee-professor-of-the-indian-academy-of-sciences/

Increased profile for unit and awareness of research.</gtr:impact><gtr:outcomeId>mutHdjbCFEn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Feature on Cambridge University news site (2)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8F42B17E-A138-4E57-A304-D4C47B5E1E69</gtr:id><gtr:impact>News feature on international cancer research collaboration with high-profile institutions in India supported by c.&amp;pound;11million from the Indian Government. http://news.admin.cam.ac.uk/news/2012/10/05/breakthrough-medical-research-collaboration-receives-indian-government-funding-boost/

Increased profile for unit and awareness of research.</gtr:impact><gtr:outcomeId>NKHMRw2qjRn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BBB8CCA2-BE92-4BEC-BF47-5D7EF0B6248F</gtr:id><gtr:impact>Around 2000 visitors passed through the Biology Zone where the CCU stand was located. We spoke to many adults about cancer research as children took part in hands on activities.

Increased awareness of cancer research and the work of the unit.</gtr:impact><gtr:outcomeId>bkwFdkv9VXb</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Feature in Cambridge News</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>04B49A85-DFBA-4953-A5B3-448320F9DC7B</gtr:id><gtr:impact>Appeared in a feature on the Unit in the Cambridge News, the city's local newspaper which has regional reach across the county. Feature included in both print and online versions, increasing audience. http://www.cambridge-news.co.uk/Health/Health-and-wellbeing/A-decade-of-discovery-in-cancer-fight-at-Addenbrookes-30042012.htm

Increased awareness of cancer research and the work of the unit.</gtr:impact><gtr:outcomeId>sdfkUMbguzt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cambridge-news.co.uk/Health/Health-and-wellbeing/A-decade-of-discovery-in-cancer-fight-at-Addenbrookes-30042012.htm</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival 2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E52C476E-69DA-4479-8180-C9E821BAD6F3</gtr:id><gtr:impact>Around 4,000 people passed through the Biology Zone, with many taking part in our activities, reading posters, etc.

Increased profile for unit, and engagement with a younger audience.</gtr:impact><gtr:outcomeId>CBNmRcqwbKf</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article in Cambridge News</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2C53B7FB-37D3-416B-B430-DDD4A8812AAC</gtr:id><gtr:impact>News article in regional newspaper (print and online) on recent research publication.

Increase in unit profile.</gtr:impact><gtr:outcomeId>mLE4uGDbo2z</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cambridge-news.co.uk/Health/Health-news/Cancer-researchers-in-Cambridge-discover-how-cells-repair-their-DNA-to-avoid-cancer-20131007060913.htm</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centenary Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4D408E5E-9FF8-4873-9C1D-80B2D41ACAD8</gtr:id><gtr:impact>Around 100 pupils and teachers visited the unit, took part in hands-on activities and heard from our cancer researchers about their careers.

Increased engagement with local schools.</gtr:impact><gtr:outcomeId>ANG5xwBfPU4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>294540</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust SDDI</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>722D7CE8-6FC7-4D5D-BB9B-214C903E7864</gtr:id><gtr:outcomeId>GoYKiFmL1je</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>115000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CCC PhD Studentship - Campbell</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Cambridge Cancer Centre</gtr:fundingOrg><gtr:id>B9F8D8C1-A7B2-4202-869D-B3292399FA0F</gtr:id><gtr:outcomeId>JTvc8kNh2Yr</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Fellowship (Studentship) - S Ahmad</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Cambridge Cancer Centre</gtr:fundingOrg><gtr:id>9CCA7A95-89B8-4EAD-B41E-9504D9101E29</gtr:id><gtr:outcomeId>skcNhBX8Z8g</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GATES Scholarship- Fries</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>10278292</gtr:fundingRef><gtr:id>9BDC6E8E-FA03-4421-A936-CE171E10FD68</gtr:id><gtr:outcomeId>tyB9GTPa1B3</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Academy of Medical Sciences</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>E2355B9A-D704-415A-9CE8-489ADF3646A1</gtr:id><gtr:outcomeId>BBTnvpe8cxF</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>352371</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Aurora-A SDDI</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>06A1F7A6-B11C-4135-B09E-BE345E102C7A</gtr:id><gtr:outcomeId>oSRscWjrJAb</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>897000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>BEAF770C-1A37-4A4D-A5DC-C482A09BBAC2</gtr:id><gtr:outcomeId>W5yXaWSwxfq</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Improved methods for the characterisation of an interaction site on a target protein that modulates the phenotype of a mammalian cell, such as a phenotype other than death and/or reduced growth. Such methods include those to identify a target protein that modulates such a phenotype of a mammalian cell, and optionally to characterise an interaction site on said target protein. The invention also relates to methods of: identification of a ligand, such as a small molecule ligand, that bind to such a target protein and identification of a compound being a candidate modulator of said phenotype of a mammalian cell.

PCT Application PCT/AU2013/000110 7th February 2013
US national application 14/377,809.</gtr:description><gtr:grantRef>G1001521</gtr:grantRef><gtr:id>5A7463BE-E3D7-4E01-A432-16B5B15A4F32</gtr:id><gtr:impact>Unknown</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>57a1df43aa33f8.14948364</gtr:outcomeId><gtr:patentId>Ven-2570-11</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Target within a target</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Screening methods for peptides and nucleic acids which inhibit or block cell signalling pathways. These methods may be useful, for example, in identifying and characterising target proteins and also protein:protein interactions (PPI) sites for use as drug targets for the modulation of these pathways.

GB priority application 1426218.8 filed 13th November 2014
PCT patent application filed 12th November 2015 PCT/GB2015/053432</gtr:description><gtr:grantRef>G1001521</gtr:grantRef><gtr:id>FDF50476-8A77-4115-A019-C99029D0A76D</gtr:id><gtr:impact>Unknown</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>57a1de8356db29.34900708</gtr:outcomeId><gtr:patentId>Ven-2505-10</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Upside down screen</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The Polo Box Domain (PBD) of Polo-Like Kinase 1 and anti-mitotic compounds targeting PBD including screening campaign and associated chemistry.</gtr:description><gtr:grantRef>G1001521</gtr:grantRef><gtr:id>FF69B9BF-8C3C-4A93-B78D-E8C3DE2410EC</gtr:id><gtr:impact>Unknown</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>57a0d09b679129.02246155</gtr:outcomeId><gtr:patentId>Ven-2245-08</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>PLK-1</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>082331DD-8022-4F62-9834-AABCDB963DC4</gtr:id><gtr:title>Synthesis and biological profiling of tellimagrandin I and analogues reveals that the medium ring can significantly modulate biological activity.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a340fbb42265c9ec6bc733e0a04c590"><gtr:id>2a340fbb42265c9ec6bc733e0a04c590</gtr:id><gtr:otherNames>Zheng S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>pm_13318_28_22361895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB2D521C-4A2A-4090-B0AD-228246F240F1</gtr:id><gtr:title>Cancer suppression by the chromosome custodians, BRCA1 and BRCA2.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaeb2e81353ecad12ce5da26aad67c13"><gtr:id>eaeb2e81353ecad12ce5da26aad67c13</gtr:id><gtr:otherNames>Venkitaraman AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5436a0736524f5.66150703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5A80390-D32F-43CB-A59A-4946A4AF97E9</gtr:id><gtr:title>Selective nuclear export of specific classes of mRNA from mammalian nuclei is promoted by GANP.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5436a074086e53.17611449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1F787BD-3390-442B-8FB6-CF1E7CF71B5C</gtr:id><gtr:title>A two-directional strategy for the diversity-oriented synthesis of macrocyclic scaffolds.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b68d52fe947fbc3f051f973559d28a53"><gtr:id>b68d52fe947fbc3f051f973559d28a53</gtr:id><gtr:otherNames>O'Connell KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>pm_13318_28_22890306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3127E216-207B-4973-8590-39B5EB394483</gtr:id><gtr:title>Oncogenic KRAS triggers MAPK-dependent errors in mitosis and MYC-dependent sensitivity to anti-mitotic agents.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b77196dcbdac386045a7b78c93cc1468"><gtr:id>b77196dcbdac386045a7b78c93cc1468</gtr:id><gtr:otherNames>Perera D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d69859475d9.84005924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAFD14F9-DEF6-444F-B8BE-7209FADB850D</gtr:id><gtr:title>p53 shapes genome-wide and cell type-specific changes in microRNA expression during the human DNA damage response.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7de3df12752ce5f2ad67ba8b804a0bc"><gtr:id>f7de3df12752ce5f2ad67ba8b804a0bc</gtr:id><gtr:otherNames>Hattori H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>545e5a97e8b238.79182008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CE6841D-6857-46A7-8383-9E37F9ABA79E</gtr:id><gtr:title>Expression of LY6D is induced at the surface of MCF10A cells by X-ray irradiation.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6705d73eff6566ae63e3568b03e4702"><gtr:id>d6705d73eff6566ae63e3568b03e4702</gtr:id><gtr:otherNames>Kurosawa M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>pm_13318_28_23075424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81ABB417-8148-4D37-956A-ADE50288D7F8</gtr:id><gtr:title>A cancer-associated mutation inactivates a region of the high-mobility group protein HMG20b essential for cytokinesis.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52329ae785e789fb6117f1ddca3cd12b"><gtr:id>52329ae785e789fb6117f1ddca3cd12b</gtr:id><gtr:otherNames>Lee M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>545e5a97c09e68.33250350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59B2DB51-A02C-4264-A37B-69A74B3F271A</gtr:id><gtr:title>Pattern formation in centrosome assembly.</gtr:title><gtr:parentPublicationTitle>Current opinion in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1700422215cd472efef9d11f67e1c5b"><gtr:id>d1700422215cd472efef9d11f67e1c5b</gtr:id><gtr:otherNames>Mahen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0955-0674</gtr:issn><gtr:outcomeId>pm_13318_28_22245706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59B2F929-D48B-470A-AFAB-B1A44362679C</gtr:id><gtr:title>The breast cancer susceptibility gene BRCA2 is required for the maintenance of telomere homeostasis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04cf5b89a314c3672f71a41a524be3a3"><gtr:id>04cf5b89a314c3672f71a41a524be3a3</gtr:id><gtr:otherNames>Min J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_13318_28_22187435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC0429E3-DB2B-4077-BC44-19D6EC05FCA5</gtr:id><gtr:title>Human inositol polyphosphate multikinase regulates transcript-selective nuclear mRNA export to preserve genome integrity.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_13318_28_24074953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C51E775-02FE-498E-83AD-61C36335D0FD</gtr:id><gtr:title>Impact of Alternative Splicing on the Human Proteome.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7c92a675b6502a97a707b04cca69bc1"><gtr:id>d7c92a675b6502a97a707b04cca69bc1</gtr:id><gtr:otherNames>Liu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a2fd588967543.61841113</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BABEE0B-FC3A-4C1E-A796-4F50ACF6A3BE</gtr:id><gtr:title>Small-molecule inhibitors that target protein-protein interactions in the RAD51 family of recombinases.</gtr:title><gtr:parentPublicationTitle>ChemMedChem</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584952b12d6156f6729a395528a9a0f6"><gtr:id>584952b12d6156f6729a395528a9a0f6</gtr:id><gtr:otherNames>Scott DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1860-7179</gtr:issn><gtr:outcomeId>56e158a951dd79.34984658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0860636-46B5-47F2-B01B-E8B70B87CB43</gtr:id><gtr:title>Kruppel-associated Box (KRAB)-associated co-repressor (KAP-1) Ser-473 phosphorylation regulates heterochromatin protein 1? (HP1-?) mobilization and DNA repair in heterochromatin.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e414d79967042b7e9a6026b44adde3ec"><gtr:id>e414d79967042b7e9a6026b44adde3ec</gtr:id><gtr:otherNames>Bolderson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_13318_28_22715096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F48C5AF-834A-42B1-9DF0-D3BFA55C200D</gtr:id><gtr:title>Genome instability mechanisms and the structure of cancer genomes.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1333dc61a50bcdc0960fd1f4abc240f"><gtr:id>d1333dc61a50bcdc0960fd1f4abc240f</gtr:id><gtr:otherNames>Cassidy LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn><gtr:outcomeId>pm_13318_28_22366532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8299A015-0C1E-4FB8-B645-7D9635116C14</gtr:id><gtr:title>Palladium-catalysed cross-coupling of vinyldisiloxanes with benzylic and allylic halides and sulfonates.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/989c15fc31ab70370cc1b93bf3576260"><gtr:id>989c15fc31ab70370cc1b93bf3576260</gtr:id><gtr:otherNames>Frye EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>pm_13318_28_22678946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC98D329-764B-4193-946F-D54ED37894B9</gtr:id><gtr:title>Maximizing the biochemical resolving power of fluorescence microscopy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f542cf3e85d9fc356dcf95ba1bac77f"><gtr:id>4f542cf3e85d9fc356dcf95ba1bac77f</gtr:id><gtr:otherNames>Esposito A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5436a074bd82f0.77861645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9405A879-6E49-42F1-BC47-1BB22C3AA63B</gtr:id><gtr:title>The GDI-like solubilizing factor PDEd sustains the spatial organization and signalling of Ras family proteins.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bac50221dc503170820594fbe6ef3a1b"><gtr:id>bac50221dc503170820594fbe6ef3a1b</gtr:id><gtr:otherNames>Chandra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>pm_13318_28_22179043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DED5CD1C-F67F-4D6A-A375-1910FF1F8CF6</gtr:id><gtr:title>Using a fragment-based approach to target protein-protein interactions.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584952b12d6156f6729a395528a9a0f6"><gtr:id>584952b12d6156f6729a395528a9a0f6</gtr:id><gtr:otherNames>Scott DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>pm_13318_28_23344974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B61E43C1-7ABF-4589-9B67-B4D79BA7CE6B</gtr:id><gtr:title>A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0f8965e8e8465c924c0a035380d968b"><gtr:id>e0f8965e8e8465c924c0a035380d968b</gtr:id><gtr:otherNames>Jeyasekharan AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_13318_28_24013206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E03E6AE1-AFB1-40CD-ACEC-ACF9B47E5239</gtr:id><gtr:title>A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b366faa210eb4d0c0d06e001b09afa2"><gtr:id>5b366faa210eb4d0c0d06e001b09afa2</gtr:id><gtr:otherNames>Tan SLW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>5a361bbe8a3ed7.53046529</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C66C2AAC-1318-4CBB-9A4B-8AC2F6072E12</gtr:id><gtr:title>A DNA-damage selective role for BRCA1 E3 ligase in claspin ubiquitylation, CHK1 activation, and DNA repair.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10b9a6b6fc938ff29e11abdcb06d4396"><gtr:id>10b9a6b6fc938ff29e11abdcb06d4396</gtr:id><gtr:otherNames>Sato K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>pm_13318_28_22863316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>812BB6C2-558B-434B-A2BF-2DD809F14B34</gtr:id><gtr:title>Micro(mi) RNA-34a targets protein phosphatase (PP)1? to regulate DNA damage tolerance.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc329042393bda9d8373ce4d6b137310"><gtr:id>cc329042393bda9d8373ce4d6b137310</gtr:id><gtr:otherNames>Takeda Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>560cf485a20e24.00359131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30C28F13-A7A2-4044-81F5-60A4383EFFA0</gtr:id><gtr:title>Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09c7c9862afb72a36cc5a02815c918f"><gtr:id>b09c7c9862afb72a36cc5a02815c918f</gtr:id><gtr:otherNames>Russell P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_13318_28_22056875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC4E0E0B-CF33-4F95-89AE-8B3CAB04F352</gtr:id><gtr:title>A-type lamins maintain the positional stability of DNA damage repair foci in mammalian nuclei.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1700422215cd472efef9d11f67e1c5b"><gtr:id>d1700422215cd472efef9d11f67e1c5b</gtr:id><gtr:otherNames>Mahen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13318_28_23658700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4196F14E-CA3B-4F36-93E3-CB6D4C1A69E0</gtr:id><gtr:title>Chromosome instability and carcinogenesis: insights from murine models of human pancreatic cancer associated with BRCA2 inactivation.</gtr:title><gtr:parentPublicationTitle>Molecular oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1333dc61a50bcdc0960fd1f4abc240f"><gtr:id>d1333dc61a50bcdc0960fd1f4abc240f</gtr:id><gtr:otherNames>Cassidy LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1574-7891</gtr:issn><gtr:outcomeId>5436a074935226.20290992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F764442E-BEA3-4A8A-9577-484BF1880B6B</gtr:id><gtr:title>High content screening of diverse compound libraries identifies potent modulators of tubulin dynamics.</gtr:title><gtr:parentPublicationTitle>ACS medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f5b243c4d6b98f63194d44a82af0669"><gtr:id>0f5b243c4d6b98f63194d44a82af0669</gtr:id><gtr:otherNames>Laraia L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1948-5875</gtr:issn><gtr:outcomeId>54369fff59f1d9.42388833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28AEEADB-0032-48F6-A853-523F5AAAD147</gtr:id><gtr:title>Fast and simple spectral FLIM for biochemical and medical imaging.</gtr:title><gtr:parentPublicationTitle>Optics express</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7112117de6a6278abb94866d1e21364"><gtr:id>e7112117de6a6278abb94866d1e21364</gtr:id><gtr:otherNames>Popleteeva M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1094-4087</gtr:issn><gtr:outcomeId>560cf485695426.64147424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>034F87A7-75DC-4033-84BC-F0D63FD76AA9</gtr:id><gtr:title>Diversity-oriented synthesis as a tool for identifying new modulators of mitosis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5966b8b69ea8c08c65551eb5584b90da"><gtr:id>5966b8b69ea8c08c65551eb5584b90da</gtr:id><gtr:otherNames>Ibbeson BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5436a0745dc985.18189042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>789D63BC-003D-454A-8B1B-1BAD14C4C17A</gtr:id><gtr:title>Investigating peptide sequence variations for 'double-click' stapled p53 peptides.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8586c6b180b864a824ed1eec5eb01a4"><gtr:id>a8586c6b180b864a824ed1eec5eb01a4</gtr:id><gtr:otherNames>Lau YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>5436a0733da501.21421209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80D16274-F752-476E-8955-5D23CE91FA65</gtr:id><gtr:title>Linear aliphatic dialkynes as alternative linkers for double-click stapling of p53-derived peptides.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8586c6b180b864a824ed1eec5eb01a4"><gtr:id>a8586c6b180b864a824ed1eec5eb01a4</gtr:id><gtr:otherNames>Lau YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>545e5a98179cc7.81091990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E40425A-FAB9-47C1-A593-46D889D62FF1</gtr:id><gtr:title>RNA Processing and Genome Stability: Cause and Consequence.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>56d6b2a41f6f91.00301229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AEF6427-A947-45CD-9007-695AA9A50FA5</gtr:id><gtr:title>Beyond cancer genomics: after the end of the beginning.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaeb2e81353ecad12ce5da26aad67c13"><gtr:id>eaeb2e81353ecad12ce5da26aad67c13</gtr:id><gtr:otherNames>Venkitaraman AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn><gtr:outcomeId>pm_13318_28_22402446</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8477AD0-C216-4CB4-9924-8D9A54804B95</gtr:id><gtr:title>Regulation of constitutive and alternative mRNA splicing across the human transcriptome by PRPF8 is determined by 5' splice site strength.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>560cf4852d82c6.89842347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95B4A3A4-C632-4B16-BECC-22C18C024E4B</gtr:id><gtr:title>Homeostatic control of polo-like kinase-1 engenders non-genetic heterogeneity in G2 checkpoint fidelity and timing.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24ec375abd205ba8e96b7e4e07a57e2b"><gtr:id>24ec375abd205ba8e96b7e4e07a57e2b</gtr:id><gtr:otherNames>Liang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5436a0730c63b3.24331542</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001521</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>